Zobrazeno 1 - 10
of 78
pro vyhledávání: '"P.J. Zilko"'
Autor:
P.J. Zilko, Arada Rojana-udomsart, Frank L. Mastaglia, Vicki Fabian, Susan E. Walters, Peter Hollingsworth
Publikováno v:
Journal of Clinical Neuromuscular Disease. 11:213-222
Objective: To describe a form of inflammatory myopathy with prominent involvement of the paraspinal and scapular muscles in patients with scleroderma. Methods: Review of clinical records, laboratory investigations, and muscle biopsies. Results: Patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::027d89dc556ffaef4c759d0af1408991
https://doi.org/10.1097/cnd.0b013e3181c139f6
https://doi.org/10.1097/cnd.0b013e3181c139f6
Autor:
Wally Knezevic, Frank L. Mastaglia, Peter K. Panegyres, Merrilee Needham, P.J. Zilko, Victoria A. Fabian
Publikováno v:
Neuromuscular Disorders. 17:194-200
Statins can cause a necrotizing myopathy and hyperCKaemia which is reversible on cessation of the drug. What is less well known is a phenomenon whereby statins may induce a myopathy, which persists or may progress after stopping the drug. We investig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f369f2953b0e80409cc311a619360c5
https://doi.org/10.1016/j.nmd.2006.10.007
https://doi.org/10.1016/j.nmd.2006.10.007
Autor:
Timothy Day, Frank T. Christiansen, L. Kiers, Richard J.N. Allcock, Nigel G. Laing, Alastair Corbett, Ian James, Frank L. Mastaglia, P.J. Zilko, Merrilee Needham, Adrian Scott, Campbell S. Witt, Michael J. Garlepp
Publikováno v:
Neuromuscular Disorders. 19:763-765
Susceptibility to sIBM is strongly associated with the HLA-DRB1*03 allele and the 8.1 MHC ancestral haplotype (HLA-A1, B8, DRB1*03) but little is known about the effects of allelic interactions at the DRB1 locus or disease-modifying effects of HLA al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1df8fcab017a6ea37d0e77f6785577e
https://doi.org/10.1016/j.nmd.2009.07.015
https://doi.org/10.1016/j.nmd.2009.07.015
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 65:107-110
A prospective open label trial of add on therapy with intravenous immunoglobulin (i.v.Ig) was carried out in 16 patients with inflammatory myopathy who had continued to deteriorate or had relapsed on conventional therapy. The response was assessed us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ebfef4bd6b520c0b7b5bc56e27e5c13
https://doi.org/10.1136/jnnp.65.1.107
https://doi.org/10.1136/jnnp.65.1.107
Publikováno v:
Muscle & Nerve. 20:651-664
The treatment of the immune-mediated inflammatory myopathies remains largely empirical. Corticosteroids are usually effective in polymyositis and dermatomyositis but may need to be combined with methotrexate or azathioprine in some patients. Intraven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92a83f6d3c06dc8df904e0ac0c019dea
https://doi.org/10.1002/(sici)1097-4598(199706)20:6<651::aid-mus1>3.0.co
https://doi.org/10.1002/(sici)1097-4598(199706)20:6<651::aid-mus1>3.0.co
Publikováno v:
BioDrugs. 7:262-272
The idiopathic inflammatory myopathies include polymyositis and dermatomyositis, which tend to be responsive to drug therapy, and inclusion body myositis, which is often unresponsive or only partially responsive to drugs. Corticosteroids are consider
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ad5267d697de8f652c52834ff9fec05
https://doi.org/10.2165/00063030-199707040-00003
https://doi.org/10.2165/00063030-199707040-00003
Publikováno v:
Physiotherapy Theory and Practice. 11:151-156
Inflammatory myopathy is a group of disorders with progressive muscle weakness being the major symptom. Quantitative assessment of muscle function is important when evaluating the response of these conditions to treatment and various methods, includi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf1d6f5e5ee612d698b2908fe08ffce8
https://doi.org/10.3109/09593989509022412
https://doi.org/10.3109/09593989509022412
Autor:
P.J. Zilko, Francis Mastaglia
Publikováno v:
Journal of Clinical Neuroscience. 10:99-101
The initial approach to the treatment of patients with inflammatory myopathy is critical in determining the subsequent course and outcome. Prolonged administration of high doses of corticosteroids should be avoided and a second-line agent such as met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79adeadd474749c0b0d89c0b0457611c
https://doi.org/10.1016/s0967-5868(02)00271-0
https://doi.org/10.1016/s0967-5868(02)00271-0
Publikováno v:
Clinical and Experimental Immunology. 98:40-45
SUMMARY Inclusion body myositis (IBM) is defined clinically by a characteristic pattern of progressive proximal and distal limb muscle weakness and resistance to steroid therapy, and histologically by the presence of distinctive rimmed vacuoles and f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab7ed1d94fb70ec3cf924b7a40441577
https://doi.org/10.1111/j.1365-2249.1994.tb06604.x
https://doi.org/10.1111/j.1365-2249.1994.tb06604.x
Autor:
Merrilee Needham, Yue-Bei Luo, Francis Mastaglia, P.J. Zilko, Susan E. Walters, Victoria A. Fabian, Arada Rojana-udomsart
Publikováno v:
Clinical neurology and neurosurgery. 113(7)
Sporadic inclusion body myositis (sIBM) usually occurs as an isolated condition, but it may occur in association with another autoimmune disorder such as Sjogren's syndrome. We reviewed sIBM cases with Sjogren's syndrome (sIBM/SS) from the Perth Infl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::364c90db1b81c408231baad9cec5bc0a
https://pubmed.ncbi.nlm.nih.gov/21507567
https://pubmed.ncbi.nlm.nih.gov/21507567